Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low-Dose Ketamine Infusion for the Treatment of Multiple Sclerosis Fatigue (INKLING-MS)

NCT05378100 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT05378100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05378100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low-Dose Ketamine Infusion for the Treatment of Multiple Sclerosis Fatigue (INKLING-MS)
Lead sponsor
Johns Hopkins University
Phase
Phase 2
Overall status
Active, not recruiting
Start date
January 1, 2023
Completion date
October 1, 2026
Enrollment
110 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis fatigue